Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar pchop123 (79.82) Submitted: 5/22/2013 3:54:41 PM : Outperform Start Price: $1.60 CBLI Score: -6.55

up up & away

Featured Broker Partners


Advertisement